Lawrence M. Blatt

Insider Reports History

SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Lesley Ann Calhoun, as attorney-in fact for Lawrence M. Blatt
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Lawrence M. Blatt

Form 4 holding President and CEO, Director

Aligos Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
105,840
Estimated value
Report date
09 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Lawrence M. Blatt

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .